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1RETINOPATHY OF PREMATURITY (ROP)
INTRODUCTION
ROP is a vaso-proliferative disorder of premature /preterm infants
with  gestational  age  less  than  32  weeks  or  birth  weight  less  than
1500gms especially those exposed to high concentration of oxygen.
The  range  of  possible  outcomes  for  patients  with  ROP  extends
from minimum sequelae with no effect on vision in mild cases to
bilateral irreversible and total blindness in advanced cases.
In India the threshold ROP has been documented even in babies
weighing 2000gram at birth. At present the cut off birth weight and
gestational age need to be increased. Early diagnosis and prompt
treatment with laser has proved to be effective in preventing progression
of ROP in this study.
2HISTORY
Retinopathy of prematurity first defined by TERRY  in 1942,
within a decade became the primary cause of childhood visual loss. He
called it retrolental fibroplasias. As the pathogenesis was better
understood the term retinopathy of prematurity was coined.
The discovery of the relationship between supplementary oxygen
and ROP in 1950s led to the practice of rigid curtailment of oxygen
supplementation in nursery.
During this period no clinical monitoring systems were available
to measure blood oxygenation.  An increase in deaths caused by
respiratory distress syndrome (RDS) was reported.
By the late 1960s and early 1970s arterial blood gas analysis had
come into general use and the oxygen requirements of premature infants
and RDS were better documented. Arterial blood gas monitoring
enabled pediatricians to titrate the incubator oxygen concentration to
more nearly meet the individual premature infant’s oxygen needs.
3EMBRYOLOGY
Michelson suggested that retinal capillaries arise by budding from
pre existent arteries and veins that originate from hyaloids vessels at the
optic nerve head. On the posterior edge of an advancing mesenchyme, a
chicken wire meshwork of capillaries develops. This fine meshwork of
vessels undergoes absorption and remodeling to produce mature arteries
and veins. The nasal part of retina is vascularised first, around 32 weeks
of gestation followed by temporal retina which vascularises at term.
4PATHOGENESIS
Alon et al demonstrated that hyperoxia caused down regulation of
VEGF  and  death  of  endothelial  cells,  suggesting  that  VEGF  is  an
endothelial survival factor. In the time that follows closure of these
growing vessels, the differentiating retina becomes increasingly
ischemic and hypoxic and VEGF is unregulated driving
neovascularisation.
The description of the mechanism of oxygen’s effects given
previously points out the initial changes in the developing vessels, and
that historically this was believed to be an injury caused by excess
oxygen.
Theoretically the provision of increased oxygen should down-
regulate the release of such growth factors. This hypothesis was tested in
the kitten model of oxygen induced retinopathy. Systemic mild hypoxia
was found to worsen the retinopathy where as mild hyperoxia improved
it. Similar results have been demonstrated in a mouse model where
VEGP is clearly one of the major growth factors involved.  A
multicenter clinical trial studied this concept in the nursery. Results
showed that once the ROP was established, raising the oxygen
5saturation mildly did not harm the ROP, but neither was it of clear
benefit. In general the study showed no statistical difference in the
progression to severe ROP between the two oxygen treatment regimens
that were tested.
The clinical and histo-pathalogical observations of Flynn and co-
workers led them to postulate the following sequence of events in the
development of ROP in human infants:
1. Injury to the endothelium occurs where it has just differentiated
from mesenchyme to form the primitive capillary meshwork. This
is  reminiscent  of  the  animal  studies  in  which  a  short  duration  of
hyperoxia resulted in capillary damage limited to the most
recently differentiated vascular complexes. It is currently believed
that environmental factors other than oxygen also are involved.
Nitric oxide and subsequent formation of peroxynitrite can
contribute to the vaso-obliterative stage of ROP. Reduced VEGF
results  in  death  of  endothelial  cells  because  of  its  role  as  a
survival factor.
62.  After injury to the vascular endothelium by some noxious agents,
the mesenchyme and the mature Arteries and the veins survive
and merge via the few remaining vascular channels to form a
mesenchymal arterio- venous shunt. The shunt replaces the
destroyed or damaged capillary bed.
3. The mesenchymal arterio- venous shunt is located at the
demarcation between the vascular and avascular retina.  Flynn
suggested that this structure represents the pathognomonic lesion
of acute ROP.
Flynn described a dormant period after the injury, which may last
from several days to months during which the retinal findings are
relatively stable. The tissue comprising the shunt may thicken, and the
grey-white initial colour of the structure turns from pink to salmon red.
He started that during this period when vasculogenic activity resumes in
the retina, the fate of the eye is decided. Flynn pointed out that the cells
inside the shunt divide and differentiates into normal capillary
endothelium. They form primitive endothelial tubes that send forth a
brush border of capillaries that grows anteriorly into the avascular
retina. This represents involution of ROP, which he observed to occur in
more than 90% of cases at this early stage.
7In progressive disease however the primitive cells inside the shunt
proliferate and erupt through the internal limiting membrane, growing
on the surface of retina and into the vitreous body. Flynn stated, it is this
lack of differentiation and destructive proliferation of cells and their
invasion into spaces and tissues where they do not belong is a chief
event in the process of membrane proliferation leading to tractional
retinal detachment.
Foos suggested a pathogenesis of ROP based on examination of
histopathologic material. He used the terms vanguard and rear-guard to
describe the cellular components of the developing retina. The vanguard
or anterior component contains a spindle shaped cells thought to be glia,
which play a role in nourishing the immature retina during its
development. The rear guard contains primitive endothelial cells. As the
retina matures the endothelial cells aggregate into cords that according
to Foos subsequently luminize and become the primordial capillaries of
retina. It is from the rear god and primitive endothelial cells that the
neovascularisation of ROP will develop.
Foos noted that as the developing vasculature reaches its most
anterior extent and matures, the spindle cells of the van guard disappear.
The spindle cells are endothelial precursors and in the fetal human and
neonatal dog retina, the precursors organise and differentiate to form the
initial retinal vasculature.
8EFFECTS OF OXYGEN ON IMMATURE RETINA
Primary Effect
Retinal vasoconstriction followed by some degree of vascular
closure if the oxygen supply is continued. Electron microscopic
observations demonstrate selective hyperoxic injury to the endothelial
cells of immature vessels without obvious changes in the neuronal
elements of the retina.
Secondary Effect
Following sustained hyperoxia when the lab animal is removed to
ambient air, a marked endothelial proliferation arises from the residual
vascular complexes immediately adjacent to retinal capillaries ablated
during hypoxia.
Nodules of proliferating endothelial cells canalise to form new
vessels that not only grow within the retina, but also erupt through the
internal the internal limiting membrane to grow on its surface, similar to
the neovascularisation in other proliferative retinopathies .Oxygen exerts
an important effect on the remodelling of the original primitive capillary
network that develops in the retina.
9Pierce and colleagues have demonstrated the correlation of vascular
endothelial growth factor( VEGF) protein production with periods of
low oxygen, as well as its disappearance after oxygenation.
Other growth factors such as adenosine and IGF-1 may also be involved.
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ZONES OF INVOLVED RETINA
ZONE 1
An imaginary circle with centre as the optic disc with a diameter,
twice the distance from the optic nerve to the macula is zone 1. The
hallmark of the disease worsening is not the presence of
neovascularisation, but is by the increasing dilation and tortuosity of the
vessels.
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ZONE 2
Zone 2 extends from peripheral border of zone 1 to a concentric
circle tangential to nasal ora serrata. Temporally this imaginary
boundary corresponds to the anatomic equator.
ZONE 3
Once the nasal vessels have reached ora serrata, zone 3 is the
remaining temporal crescent of retina anterior to zone 2. Zone 3, which
is the farthest from the disc, is the last to get vascularised.
Aggressive disease rarely is seen in this zone. Typically, this is
slowly vascularising and requires evaluations every few weeks.
Many infants show inactive disease in zone 3 with a demarcation
line and non-vascularised retina. This has been noted in toddlers and can
be considered cicatricial peripheral disease. No ill sequelae are known to
occur from this ridge.
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STAGING OF ROP
STAGE 0:
It is immature retinal vasculature without demarcation between
vascularised and non-vascularised retina.
In zone 1, this may appear as a vitreous haze, with the optic nerve
as the only landmark. Weekly examinations should be performed.
STAGE 1-Demarcation line:
Stage 1 is characterized by the presence of a demarcation line, the
first pathognomonic ophthalmic sign of ROP. The line represents a
structure separating the anterior avascular retina from the posterior
vascularised retina. It is flat and white and lies within the plane of retina.
STAGE 2 – Ridge:
The demarcation line of stage 1 acquires a height and width,
occupies a volume, and extends centripetally within the globe. Vessels
may leave the surface of the retina to enter the ridge. Small tufts of new
vessels are called popcorn lesions; these may be located posterior to the
ridge.
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? In zone 1, if there is a ridge, this is an ominous sign. The disease
is graded as threshold if there are tortuous vessels in the posterior
pole and treatment commenced within 3 days.
? In zone 2, if there are no vascular changes and the ridge has no
engorgement, the eye should be examined biweekly.
?  Pre-threshold is stage 2 with a plus disease.
In zone 3, examination every 2-3 weeks should be sufficient,
unless  of  course  there  is  any  vascular  tortuosity  or  straightening
of the vascular arcades.
STAGE 3- extra retinal fibro vascular proliferation:
The proliferating tissue causes a ragged appearance of the ridge as
the proliferation increases into the vitreous.
The extra retinal fibro vascular proliferation (neovascularisation)
may  be  present  on  the  ridge,  on  the  posterior  surface  of  the  ridge  or
anteriorly toward the vitreous cavity. The neovascularisation gives the
ridge a velvety appearance, a ragged border.
? In zone 1, if there is any neovascularisation, it is serious and
requires treatment.
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? In zone 2, pre-threshold is defined as stage 3 without plus disease,
or stage 3 with less than 5 contiguous or 8 non-contiguous hours.
? Threshold is stage 3 with at least 5 contiguous or 8 non-
contiguous hours and plus disease.
? In zone 3, examination every 2-3 weeks should be sufficient,
unless there is any vascular tortuosity or straightening of the
vascular arcades.
STAGE 4- Subtotal retinal detachment:
This stage is a subtotal retinal detachment beginning at the ridge.
The retina is pulled anteriorly into the vitreous by the fibro vascular
ridge.
? Stage 4A does not involve the fovea.
? Stage 4B involves the fovea.
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STAGE 5 - Total retinal detachment:
This stage is a total retinal detachment in the shape of a funnel.
? Stage 5A is an open funnel.
? Stage 5B is a closed funnel.
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PLUS DISEASE
Plus disease is defined as arteriolar tortuosity and venous
engorgement of the posterior pole, iris vascular engorgement, pupillary
rigidity, and vitreous haze, which are part of the sub classification given
to the above stages. The presence of plus disease is an ominous sign.
PRE-PLUS DISEASE
Pre-plus disease is defined as vascular abnormalities of the
posterior pole that are insufficient for the diagnosis of plus disease but
that demonstrate more arteriolar tortuosity and more venular dilatation
than normal. Signs of pre-plus disease early in the course of ROP were
shown  to  be  strongly  associated  with  development  of  severe  ROP  that
required laser treatment. The diagnosis of pre-plus disease adds
prognostic value beyond that already known with birth weight,
gestational age, ROP zone, and ROP stage.
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CORRELATION OF PATHOGENESIS WITH CLINICAL
CLASSIFICATION
According to Garner, the demarcation line of stage 1 ROP
morphologically comprises two relative distinct zones. The anterior
zone  is  formed  by  a  mass  of  spindle  shaped  cells,  which  are  the
progenitors of differentiated vascular endothelium. It corresponds to the
primitive mesenchyme seen in the normal fetal development but with a
considerable increase in the number of cells. It is this hyperplasia,
involving both thickening and widening, that makes the demarcation
line visible.
The demarcation according to Garner is devoid of functioning
capillaries
According to Garner the retinal ridge that characterizes stage 2
results from the proliferation of endothelial cells with organization into
vascular channels.
According to Foos, the stage 3 appears as placoid, polypoid, or
pedunculated. The placoid pattern is the most common and it correlates
with development of retinal detachment. A condensation of vitreous
body over the ridge is related to depolymerisation of hyaluronic acid and
collapse of the collagenous framework into optically visible structures.
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INVOLUTION OF ROP
Regressed ROP:  although active ROP usually involutes without
progressing to retinal detachment, cicatricial sequelae can remain even
in those cases.
Patients with regressed ROP are at risk for developing strabismus
and amblyopia early in life. Regular examination and attention to
refractive, visual, and extra ocular muscle status are indicated for all
infants who have had ROP until about age 18 months, and thereafter as
clinically indicated.
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OTHER TERMS MENTIONED WITH ROP INCLUDE THE
FOLLOWING
? POPCORN
Anterior to the internal limiting membrane a cicatrized
neovascularisation is seen which is called popcorn.
? HOT DOG
 A  red  active  ridge,  is  the  site  of  increasing  vascular  channels.  If
noted  on  zone  1  or  2,  this  is  a  dangerous  sign.  This  area  may
regress with cicatrix floating in the vitreous cavity.
? RUSH DISEASE
This is rapidly progressing subtype of ROP which does not
progress step wise from stage 1 to 5, but instead may rush to stage
5.
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GLAUCOMA IN RETINOPATHY OF PREMATURITY
Patients with advanced retinopathy who develop a shallow
anterior chamber develop acute or sub-acute glaucoma later. Some cases
may respond to topical steroids and cycloplegic agents. Parents should
be cautioned to consult an ophthalmologist if the child appears to be
having sudden discomfort or irritation of the eye.
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RISK FACTORS
? Low birth
? Prolonged supplemental oxygen
? Higher arterial carbon dioxide levels
? Cyanosis
? Apnoea
? Mechanical ventilation
? Intra ventricular haemorrhages
? Seizure
? Transfusions
? Septicemia
? In utero hypoxia
? Anemia
? Patent ductus arteriosus
? Vitamin E deficiency.
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DIFFERENTIAL DIAGNOSIS
? Familial Exudative Vitreoretinopathy is an X-linked recessive
syndrome that appears similar to ROP but occurs in full-term
infants.
? Persistent foetal Vascular can cause a traction retinal detachment
difficult to differentiate but typically unilateral and does not have
a correlation to prematurity.
? Retinoblastoma is a differential diagnosis for stages 4 and 5 of
retinopathy of prematurity presenting as leucokoria.
? Congenital cataracts
? Incontinentia pigmenti- X-linked dominant disorder manifesting
pigmentary, skin abnormalities with ocular, central nervous
system and dental abnormalities.
? Norrie’s disease is a congenital retinal dysplasia (X-linked
recessive) mimicking advanced ROP.
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ETROP FOLLOW UP CRITERIA
? Twice a week:
Zone 2, no plus, stage 3
Zone 1, no plus, stage 2
Zone 1immature, no ROP
? Every 2 weeks:
Zone 2, no plus
Immature retina or stage 1
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PROPHYLAXIS AND THERAPY
ROLE OF VITAMIN E
1. Activation of spindle cells results initially in the increase in gap
junctions between adjacent spindle cells, secondarily in the
increase in cytoplasmic volume of rough endoplasmic reticulum,
and in the synthesis and secretion of angiogenic factors.
2. Maturation of spindle cells is associated with a decrease in gap
junctions , a diminished cytoplasmic volume of rough
endoplasmic reticulum and a cessation of synthesis and secretion
of angiogenic factors.
3. Myofibroblasts invade the vitreous concommtantly with spindle
cell maturation and provide the tractional force that can produce
the retinal separation.
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CRYOTHERAPY
The ablative treatment of the peripheral retina of immature infants
with ROP may ameliorate the course of  the disease.  CRYO-ROP study
was organized in 1985 under the chairmanship of Palmer. Supported by
the national eye institute the study began enrolling premature infants
weighing 1250 grams or less at birth in 1986.
Infants eligible for cryotherapy trial had stage 3 ROP involving 5
or more clock hours of retina posterior to zone 3 in the presence of a
standardized plus disease. Contiguous non-overlapping spots of trans-
scleral cryotherapy were directed at the entire anterior cuff of avascular
retina.
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LASER
In an effort to reduce the time and stress accompanying
cryotherapy, refinements of ablative therapeutic technique were studied-
in particular, laser therapy using the binocular indirect ophthalmoscope
delivery system (LIO). During the early 1990s laser ablation gained
acceptance as an alternative to cryotherapy. In general, ophthalmologists
have found that the LIO delivery system is technically easier than
cryotherapy and creates fewer postoperative sequelae related to the
treatment (inflammation and swelling) than cryotherapy. Furthermore it
seemed apparent that the outcomes of treatment of threshold disease in
zone 1 and posterior zone 2 were superior to cryotherapy and at least
equivalent to cryotherapy results for zone 2 disease.
When LIO delivery systems became available around 1990, the
only laser offered was an argon photocoagulator(488-532nm).
Subsequently the diode laser (810nm) photocoagulator was introduced.
It has become more popular than argon because of its portability and
lower incidence of postoperative cataract formation. Although
circumstances may require taking patients to the operative suit for ROP
laser  therapy,  it  can  also  be  done  in  the  NICU,  with  the  patient  under
local anesthesia, and with or without the aid or conscious sedation.
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A technique of laser treatment in NICU is to place the infant
swaddled in a blanket in an open warmer. Mydriatic drops are instilled
an hour before beginning surgery. Treatment is performed with the aid
of  the  infants’  nurse  and  a  neonatologist  is  always  available  in  the
nursery should resuscitation be necessary. A heart rate monitor, apnoea
monitor, and pulsoxymeter are used throughout the procedure to alert
the surgeon and nurse about any systemic problems. Topical anesthesia
is instilled in the eye to be treated and then a lid speculum is placed.
Lidocaine 2% is injected subconjunctivally in each quadrant(0.25-0.3cc)
for local anesthesia. Approximately 10 minutes is allowed for the
anesthetic to take effect. Treatment is then begun with the LIO delivery
system, generally with a 28 D condensing lens for reviewing.
Appropriate laser safety precautions have to taken for protection of all
personnel within the line of sight of the laser beam.
Photocoagulation burns are distributed 0.5-1 burn width apart.
The  objective  of  the  treatment  is  to  scatter  burns  throughout  the  entire
peripheral non-vascularised retina. This can be usually be accomplished
in one treatment session. Treatment is generally started at the anterior
edge of the vascularised retina and applied out to the ora serrata utilizing
a swab or like instrument for eye positioning and sclera depression when
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necessary to treat the peripheral retina. Initial settings for the diode laser
are a power of 0.15 watts and pulse duration of 0.3-0.4 seconds. The
power settings are usually sub-threshold for photo-coagulation. Power is
then titrated up in increments of 50 M watts until a yellowish-grey
reaction is observed in the retina. The power and pulse duration often
need to be varied from one area to another in the avascular retina.
The total number of laser applications necessary to treat a given
eye will depend primarily on the size of the avascular zone in the eye ;
eyes with vascularisation only into zone 1 will require a larger number
of laser spots than those with disease in zone 2. If the ROP is in mid to
peripheral zone 2, then 600 to 1000 laser spots may be sufficient to
cover the entire non-vascularised retina for 3600.  However if the eye to
be treated as vessel growth only in zone 1, then it is not unusual to apply
1500-2000 laser spots for adequate coverage. Although the desire is to
perform all the necessary treatment for each eye in one session,
circumstances such as reduced visibility or patient distress may
necessitate more than one treatment session. Occasionally, inadvertently
skipped areas near the ROP ridge require supplementary treatment in
10-14 days, in the absence of signs of involution.
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COMPLICATIONS OF LASER PHOTOCOAGULATION:
Like any other surgical procedure, photocoagulation may
occasionally be associated with complications. the most serious
complications are caused by excessive energy or misdirected
light.constant attention must be paid to the foveal  centre during any
laser treatment to avoid hitting this vital structure,
? Inadvertent corneal burns which can lead to opacities
? Iritis
? Iris atrophy
? Papillary abnormalities due to thermal damage to the ciliary
nerves in the supra choroidal  space.
? Absorption by lens pigments may create lenticular burns and
opacities
? Optic neuritis from treatmentdirectly to or adjacent to the disc
? Nerve fibre damage may follow intense absorbtion in zones of
increased pigmentation or retinal thinning.
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? Foveal burns
? Bruch’s mwmbrane ruptures,
? creationa of retinal or choroidal lesions like tear or hole.
? Exudative retinal detachment
? Rhegmatogenous retinal detachment.
Accidental foveal burns:
Great care must be taken to identify fovea . frequent reference to
foveal centre throughout the session is helpful to avoid losing track of
where in the fundus the treatment is taking place.
Bruch’s membrane ruptures:
Small spot size, high intensity , and long duration of applications
all increase the risk of a Bruch’s membrane rupture , which may
subsequently give rise to hemorrhage from choriocapillaries.
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CICATRICIAL DISEASE:
About  20%  of  infants  with  active  ROP  develop  cicatricial
complications, which range from innocuous to extremely severe. In
general, the more advanced or the more posterior the proliferative
disease is at the time of involution, the worse the cicatricial sequelae.
STAGE 1:
Peripheral retinal pigmentary disturbance and haze at the vitreous
base.
STAGE 2:
Temporal vitreo-retinal fibrosis and straightening of vascular
arcades followed by dragging of the macula and disc occurs in this
stage. This may lead to a pseudo- exotropia due to resultant
exaggeration of angle kappa.
STAGE 3:
More severe peripheral fibrosis with contracture and falciform
retinal fold is seen.
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STAGE 4:
Partial ring of retrolental fibro-vascular tissue with partial retinal
detachment may occur.
STAGE 5:
Complete ring of retrolental fibro vascular tissue with total retinal
detachment occurs. This stage was formerly called as retrolental
fibroplasia.
Part Two
33
A STUDY ON CLINICAL OUTCOMES OF LASER
PHOTOCOAGULATION FOR PREMATURE
RETINOPATHY
AIM
To study the outcomes of laser photocoagulation for premature
retinopathy.
PRIMARY OBJECTIVE:
? To analyze the outcomes of laser photocoagulation in retinopathy
of prematurity.
SECONDARY OBJECTIVE:
? Prevention of complications of retinopathy of prematurity by
arresting disease process at an earlier stage.
? Assessing the percentage of occurrence of various stages of ROP.
34
INCLUSION CRITERIA (BASED ON INTERNATIONAL
CLASSIFICATION OF ROP):
? Birth weight <1500g .
?  <32 weeks of gestational age.
EXCLUSION CRITERIA:
? Babies with birth weight more than 1500 gram.
? Infants with gestational age more than 32 weeks.
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MATERIALS AND METHODS
Sick preterm babies treated for respiratory distress syndrome /
pneumonitis by supplementary oxygen were screened.
Other co-morbid conditions such as neonatal hyper-bilirubinemia
treated by phototherapy or multiple blood transfusions were included in
the study.
Registration:
Registration was done with an ROP screening number using the
proforma.
Details of gestational age, post-conceptional age, birth weight, post
natal age were noted in the ROP screening proforma.(figure 1).
Screening conditions:
Examination of the infants was conducted in ROP screening
cubicle.
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 A/C and fan are avoided to prevent hypothermia. Babies were
wrapped adequately with a sterile cloth which facilitates examination by
restricting  movements  of  the  baby  as  well  as  providing  warmth  to  the
baby.
Care was taken not to disturb the external mileusis of the baby who are
in intensive care unit under artificial ventilator supports. (figure 2)
Aseptic precautions were undertaken like washing hands, wearing
cap and mask. Sterilized pediatric wire speculum and sclera indenters
were used for fundus examination.
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Screening process:
? The infants satisfying the inclusion criteria are registered.
? Anterior segment examination is done to rule out hazy cornea,
shallow anterior chamber, rigid pupil, leukocoria.
? Pupil is dilated with 0.25% tropicamide and 0.5% phenylephrine.
? 0.5% paracaine is used as topical anesthetic.
? Fundus evaluation is done using indirect ophthalmoscope and
20D convex lens.
? Pediatric speculum and scleral indenter are used to view the
retinal periphery.
? The findings are recorded in the screening register with diagrams
and plan of management.
? Infants with threshold ROP or higher stage are planned for laser
photocoagulation.
38
Staging of ROP:
? Stage 1 – demarcation line between the perfused and non-
perfused retina
? Stage 2 – ridge formation between the perfused and non-
perfused retina as the demarcation line acquires a height and
width
? Stage 3 – extra retinal fibro vascular proliferation occurs at the
site of ridge   (figure 3).
? Stage 4 – subtotal Retinal Detachment
? Stage 4A does not involve the fovea.
? Stage 4B involves the fovea.
? Stage 5 - total retinal detachment.
? Stage 5A is an open funnel.
? Stage 5B is a closed funnel.
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TREATMENT PROTOCOL (ETROP - EARLY TREATMENT
ROP):
? ETROP type 1 – zone 1, any stage, plus
                            Or stage 3 without plus,
                             Zone 2, stage 2 or 3,
                             With plus    (Pre-threshold).
Figure 4 shows plus disease (venous tortuosity in the posterior
pole).
Figure 5 shows stage 3 in zone 2 of the same child (extra retinal fibro
vascular proliferation).
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OBSERVATION AND ANALYSIS
LASER INDIRECT OPHTHALMOSCOPY:
The pupils are dilated with 0.25% tropicamide and 0.5%
phenylephrine. 0.5% paracaine is applied topically to anaesthetize the
eye. The infant is monitored with a pulsoxymeter by a neonatologist.
Photocoagulation of peripheral retina is done using a frequency
doubled Neodymium- YAG laser of wavelength 532nm by indirect
ophthalmoscope. Antibiotic and anti inflammatory eye drops are given 4
times a day for 1 week following laser. Figure 6 shows post laser fundus
picture of the stage 3 plus disease.
The total number of laser applications necessary to treat a given
eye will depend primarily on the size of the avascular zone in the eye ;
eyes with vascularisation only into zone 1 will require a larger number
of laser spots than those with disease in zone 2. If the ROP is in mid to
peripheral zone 2, then 600 to 1000 laser spots may be sufficient to
cover the entire non-vascularised retina for 3600.  However if the eye to
be treated as vessel growth only in zone 1, then it is not unusual to apply
1500-2000 laser spots for adequate coverage. Although the desire is to
perform all the necessary treatment for each eye in one session,
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circumstances such as reduced visibility or patient distress may
necessitate more than one treatment session. Occasionally, inadvertently
skipped areas near the ROP ridge require supplementary treatment in
10-14 days, in the absence of signs of involution.
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THE ETROP RECOMMENDATIONS FOR FOLLOW UP:
Twice a week if there is type 2 ROP
? Zone 2, no plus, stage 3 (or with plus, stage 1)
? Zone 1 , no plus,stage 1 or 2
Every week if the ROP is near type 2
? Zone 2 , no plus, stage 2
? Zone 1 , immature , no ROP
Every 2 weeks if less concerning
? Zone 2 , no plus, immature or stage 1
Favourable signs with respect to progression or involution of ROP
include attainment of post-menstrual age of 45 years without developing
atleast type 2 ROP and either the completion of full retinal
vascularisation or progression of retinal vascularisation into zone 3
without previous              zone 2 ROP.
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Until ROP can be prevented, it behooves us, the physicians caring
for the premature infants to detect cases that need treatment through co-
ordinate and timely methods in order to benefit each of our recovering
pre-term patients.
Neonatologists, ophthalmologists discharge coordinators and ROP
coordinators must collaborate in adhering to local policies that are
developed for the benefit of theses infants.
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RESULTS
Totally 202 babies were screened in a duration of two years. The
mean gestational age of babies screened was 30.25 weeks and the mean
birth weight was 1.25 Kg. out of the 202 babies screened, 73 babies had
ROP. Three pairs of twins were also affected by ROP among others. Out
of the 73 ROP babies 17 required laser treatment. 14 of those who were
treated with laser recovered whereas 3 babies progressed to retinal
detachment, most probably due to late stage of presentation. The
probability value was found to be 0.008 which is significant.
No. of babies examined : 202
Mean gestational age : 30.25 wks
Mean birth weight : 1.25 kg
No. of babies diagnosed to have ROP - : 73
No. of twins diagnosed to have ROP :  3
No. of babies who were given laser : 17
No. of babies with regressed ROP following laser : 14
No. of babies who progressed to RD even after laser     : 3
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DISCUSSION
From the data collected, it is found that out of the 202 babies
screened, 73 babies had ROP. Out of the 73 ROP babies, 17 required
laser photocoagulation, out of which 14 responded very well, but 3 did
not respond.
According to Chi-square test,
 X2 = 7.11
The P value is significant
The three babies which progressed to total retinal detachment had
been brought for screening only in the late stages, that is, in stage 4 with
or  without  plus  disease.  This  shows  that,  early  diagnosis  and
management is the mainstay of treatment of retinopathy of prematurity.
Parents’ education regarding the importance of periodic follow up
is very important.
Surgical management for stage 5 has poor prognosis.
P = 0.008
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Majority of the babies affected by ROP were male. Regular screening
helps detect ROP in an early stage as shown in the chart depicting the
percentage of occurrence of various stages of ROP Intra-vitreal anti-
vascular endothelial growth factor can be given but visual prognosis is
not as good as that following laser photocoagulation.
Birth asphyxia is one the major risk factor in the development of
ROP.
Out of 73 babies diagnosed to have ROP, 17 required laser of
which 14 recovered. This shows the better visual outcome following
laser.
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CHART SHOWING THE NUMBER OF ROP BABIES
REQUIRING LASER
56
17
ROP non lasered
ROP Lasered
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SUCCESS OF LASER IN ROP
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Percentage chart showing the significance of positive
pressure ventilation in the occurrence of ROP:
73.68%
15.79%
10.53%
CPAP
Oxygen hood
Hyperbaric oxygen
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Sex Predilection:
males
females
35%
65%
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Chart showing the various co morbid
condition associated with ROP:
1. Neonatal hyperbilirubinemia 6%
2. Birth asphyxia 64%
3. Seizures7%
4. Neonatal septicemia 5%
5. Pneumonitis 2%
6. Respiratory distress syndrome 16%
1
2
3
4
5
6
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Chart showing the relative occurrence of various stages of ROP
stage 1
stage 2
stage 3
stage 4
29
24
12
2
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MATURITY OF RETINA VS GESTATIONAL AGE
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Figure 1:
ROP evaluation form
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Figure 2:
ROP baby with ventilator support in a
neonatal intensive care unit
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Figure 3:
Zones of Involvement of ROP
57
Figure 4:
Plus disease
58
Figure 5:
Extra retinal fibro-vascular proliferation – stage 3 in  zone 2
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Figure 6:
 Post laser status showing regressed ROP
60
Figure 7:
Peadiatric speculum for better exposure
61
Figure 8:
Tortuos vessels in the posterior pole
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Figure 9:
Popcorn neovascularisation
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Figure 10 :
Pre-retinal hemorrhages in zone 3
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Figure 11:
Regressed ROP following laser burns in the
periphery seen as dark spots
65
Figure 12:
New vessels in zone 2 infero-temporally with plus disease
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Figure 13:
Scleral indentation to view the periphery of retina
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Figure 14:
Frequent application of lubricating eye drops to
prevent dryness of cornea.
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Figure 15:
Regressed vascular fronts following laser
69
Figure 16:
Well dilated pupil for adequate photocoagulation of the periphery
70
Figure 17:
Premature babies undergoing phototherapy for neonatal
hyperbilirubinemia  which is one of the risk factor for ROP
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The pictures depict the various observations during the examinations
and laser photo coagulation therapy. The explanation to the pictures is as
follows. Risk of hypothermia is predominant in premature and pre term
infants. Wrapping up the baby is very essential to avoid the risk of
hypothermia in premature or preterm infants. Most of them would be on
phototherapy for hyper-bilirubinemia as shown in figure 17. Hence
maintenance of thermal equilibrium is important.
 The limbs and the body are covered as shown in figure 13. This is
called mummification.  For adequate exposure of the peripheral retina, a
well dilated pupil is needed as shown in figure 16. Pediatric speculum
and sclera indentation helps the examiner to view all the zones of retina
as shown in figure 13.
Figure 8 shows the posterior pole with tortuous vessels  suggestive of
plus disease.
Figure 12 shows neovascularisation in zone 2 associated with tortuous
vessels in the posterior pole. Figure shows the post laser status of the
same baby with regressed ROP. The laser burns are seen as hyper
pigmented spots in the periphery.
Figure 12  shows new vessels at the junction of perfused and non-
perfused retina.   Figure 10 shows pre-retinal hemorrhages marked in
black circles. These are suggestive of leak from the new abnormal
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vessels. Figure 11 shows the post laser status of the baby with stage 3
with plus disease. The laser marks are visible as dark spots in the
periphery.
Frequent application of tear substitutes is essential to prevent dryness of
cornea both during examination by indirect ophthalmoscope as well as
during laser as shown in figure 14.
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CONCLUSION
Retinopathy of prematurity is a potentially blinding disorder
which  can  be  prevented  from  progressing  to  blindness  if  timely
screening is undertaken. Premature/ pre-term babies and babies at
increased risk such as birth asphyxia, respiratory distress syndrome,
hyper-bilirubinemia, positive pressure ventilation etc need to be
followed  up  according  to  the  Early  Treatment  of  ROP  study.  Pre-
threshold/threshold ROP needs immediate intervention with laser.
Following laser, periodic follow up needs to be done to look for the
response. If not responding, then further sittings of laser need to be
given.
The prognosis following laser in the threshold / pre-threshold
stage is very good. From the study it is found that 14 out of 17 babies
responded very well. 9 babies responded with a single sitting of laser
itself. 2 babies who were not brought for screening by the parents earlier
were diagnosed to have stage 3 ROP in zone 1 with plus disease, did not
respond to laser and progressed to stage 4. They were referred to centers
where surgeries for retinal detachment and anti vascular endothelial
growth factor were given but the retinal detachment persisted.
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This shows that early and periodic screening is the mainstay in
early detection and management which influences the outcome and
visual prognosis.
The babies are followed up till 42 weeks post-conceptional age or
till retina matures completely.
Regular follow up till age 12 years is required to correct
refractory errors or diagnose late complications like cataract, strabismus,
tractional RD, high myopia, secondary open angle glaucoma.
Prevalence  of  ROP  was  found  to  be  18.8%  as  against  23.27%,
according to the study conducted in AIIMS in the year 2010.
There is male preponderance. Twins are invariably affected
probably due to low birth weight, hyperbilirubinemia and positive
pressure ventilation in them. Among the risk factors evaluated birth
asphyxia was found to have a higher risk of developing ROP. Regular
screening would help in detecting early ROP in stage 1 which would
help prevent progression to higher stages which would lead to blindness
if not treated at the right time.
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73.33% of the babies who were given laser were followed for 6
month and found to have regressed ROP. The follow will be continued
annually till 12 years to correct the refractory errors and prevent
amblyopia.
Part Three
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PROFORMA
Name:
ROP registration number:
Gestational age:
Post conceptional age:
Birth weight:
MRD number:
Birth date:
Examination date:
Birth history:
History of supplementary oxygen:
ANTERIOR SEGMENT:
Rubeosis iridis:
Corneal abnormality:
Glaucoma:
FUNDUS DIAGRAM:
Vitreous hemorrhage:
Plus disease:
Pre-threshold:
Threshold:
DIAGNOSIS: OD /OS
Threshold/ pre-threshold/no ROP
Number of clock hours involved __________________
Re-examine in ___________ weeks.
30. Physician’s signature:
Master Chart
MASTER CHART
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
1 161/11 1.3 32 45 BE zone 3 stage 2 Biweekly follow up Regressed
2 183/11 1.2 31 37 BE zone 3 stage 3 Weekly follow up Regressed
3 186/11 1.2 30 36 BE zone 3 stage 2 Biweekly follow up Regressed
4 160/11 1.15 32 46 RE stage 1 zone 3
LE NAD
Biweekly follow up Regressed
5 161/11 1.3 32 46 BE zone 3 stage 2 Biweekly follow up Regressed
6 189/11 1.5 32 37 BE stage 2 zone 3 Biweekly follow up Regressed
7 191/11 1.33 34 37 BE stage 2 zone 3 Biweekly follow up Regressed
8 196/11 1.7 32 38 BE regressed ROP Monthly follow up Regressed
9 197/11 1.04 33 37 RE stage 2 zone 3 Biweekly follow up Regressed
10 141/11 1.8 28 43 BE regressed ROP Monthly follow up Regressed
11 188/11 1.2 30 39 RE stage 2 zone 2
3 clock hours
Biweekly follow up Regressed
12 185/10 1 28 32 BE stage 2 zone 3 Biweekly follow up Regressed
13 208/11 1.3 28 33 BE stage 2 zone 3 Biweekly follow up Regressed
14 213/11 1 29 35 BE stage 1 zone 3 Biweekly follow up Regressed
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
15 221/11 1.25 33 40 BE stage 1 zone 3 Biweekly follow up Regressed
16 212/11 1.1 28 34 BE stage 1 zone 3 Biweekly follow up Regressed
17 225/11 1.4 30 38 BE stage 3-4 zone
3
PRP 2 sittings regressed
18 213/11 1 32 36 Zone 2 stage 3 Laser 1 sitting regressed
19 245/11 1.25 34 40 BE zone 3 stage 1 Biweekly follow up Regressed
20 246/11 1.2 28 32 BE stage 1 zone 2 Biweekly follow up Progressed to
plus disease,
hence laser
given, regressed
21 251/11 1.3 28 34 RE zone 3 stage 1,
LE zone 2 stage 2
Biweekly follow up Regressed
22 256/11 1.36 31 36 BE stage 2, zone 2
, plus disease
laser regressed
23 254/11 1.22 29 36 BE stage 2 , zone 3 Biweekly follow up Regressed
24 262/11 1.25 30 34 RE stage 2, zone 2,
plus, LE stage 3,
zone 2 plus
2 sittings laser Developed NVE
RE, LE
regressed
ROP,2nd sitting
laser given for
RE
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
25 262/11 1.25 30 37 NVE persistent
inferiorly
3rd sitting laser BE regressed
26 258/11 700gm 26 31.5 Stage 1 zone 3 BE Biweekly follow up Regressed
27 269/12 1.3 30 34 BE stage 1 zone 2
with plus
2 sittings laser Regressed
28 272/12 1.25 32 36 Plus disease 1 sitting laser Regressed
29 279/12 1.6 36 40 Stage 1 , zone 2 Biweekly follow up Regressed
30 288/11 920gm 24 28 Stage 2 , zone 2
with plus disease
PRP BE Regressed
31 292/11 1 30 42 BE stage
4b,cryopexy and
PRP BE done in a
private hospital
Biweekly follow up Persistent
RD
32 293/11 1.75 36 38 Stage 3 zone 2
with plus BE
PRP BE Regressed
33 209/11 1.48 28 31 Stage 1, zone 3 Biweekly follow up Regressed
34 283/12 1.5 36 50 Stage 2 , zone 3 Biweekly follow up Regressed
35 305/12 850gm 28 36 RE stage 2 zone 1
in 3 clock hours
Biweekly follow up Regressed
36 03/10 677gm 28 32 Be plus disease BE PRP Regressed
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
37 20/10 1.29 28 33 BE stage 3 zone2 Biweekly follow up Regressed
38 46/10 1.08 28 34 BE stage 3 zone 2 2 sittings PRP Regressed
39 56/10 1.02 30 38 BE stage 4A
Post laser , post
macugen status
Weekly follow up
Persistent  stage
4a
40 85/10 980 gm 30 34 RE stage 3 plus
disease
LE stage 2  zone 2
plus
2 sittings PRP No response
41 89/10 1.40 32 36 RE zone 3 stage 1,
LE zone 3
immature
Biweekly follow up Regressed
42 91/10 1.33 32 40 RE zone 3 stage
2,LE zone 3 stage
1
Biweekly follow up Regressed
43 92/10 1.14 32 40 RE zone 3 stage
1,LE immature
Biweekly follow up Regressed
44 74/10 1.5 32 42 BE stage 1 zone 3 Biweekly follow up Regressed
45 98/10 960gm 28 34 BE spontaneously
regressed zone 3
stage 3
Monthly follow up Regressed
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
46 99/10 1.09 28 31 RE zone 3
immature, LE
stage 1 zone 2
Biweekly follow up Regressed
47
103/10
2 32 40 LE resolved ROP,
RE immature
Monthly follow up Regressed
48 112/10 1.14 31 36 BE aggressive
posterior ROP with
NVE
Laser, 2 sittings Regressed
49
116/10
1.016 30 37 RE stage 2 zone 3,
stage 3 zone 2, LE
stage3 zone 3
Weekly follow up Regressed
50 123/10 1.65 34 43 RE regressing
stage 3 2 clock
hours, LE stage 3
,mild plus, pre-
threshold
Laser, 3 sittings Regressed
51 131/10 1.8 32 40 RE stage 1 zone 2,
LE immature retina
Biweekly follow up Regressed
52 126/10 1.78 28 35 RE stage 2, 4-5
clock hours, pre-
threshold LE stage
2- 5 clock hours
laser Regressed
53 131/10 1.2 30 36 BE stage 1 zone 2 Biweekly follow up Regressed
54 62/10 1.38 51 31 BE regressed ROP
stage 2 zone 3,
Regressed
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
55 133/10 1.1 29 33 RE stage 1 zone 3,
LE stage 1 zone 3
5 clock hours
Biweekly follow up
Regressed
56 120/10 1.2 28 38 LE stage 1RE
stage 2
Biweekly follow up Regressed
57 121/10 900gm 32 44 RE stage 2
regressed ROP, LE
temporal retina
immature
Biweekly follow up Regressed
58 137/10 1.14 29 34 LE stage 1 Biweekly follow up Regressed
59 134/10 1.45 31 35 RE zone 3 stage
1,LE immature
Biweekly follow up Regressed
60 150/11 1.14 29 38 RE stage 1 3clock
hours, LE stage 1
Biweekly follow up Regressed
61 152/11 1.3 31 35 RE stage 3 zone 3,
LE stage 3 zone 2
Biweekly follow up Regressed
62 140/11 1.4 25 36 BE stage 1 zone 3 Biweekly follow up Regressed
63 157/11 1.66 32 36 RE  stage 3 zone
1,LE immature
Biweekly follow up Regressed
64 145/11 1.7 30 36 BE stage 1 zone 3 Biweekly follow up Regressed
65 162/11 1.2 32 36 RE stage 1 zone 3,
6-12’0 clock
position, LE
immature retina
Biweekly follow up Regressed
SERIAL
NO:
ROP
REGISTRATION
NUMBER
BIRTH
WEIGHT
GESTATIONAL
AGE
POST-
CONCEPTIONAL
AGE
DIAGNOSIS
TREATMENT/
FOLLOW UP
OUTCOME
66 161/11 1.3 32 42 BE stage 1,3 clock
hours temporally
Biweekly follow up Regressed
67 160/11 1.15 32 42 RE stage 1 zone
3,LE stage 1 zone
3
Biweekly follow up Regressed
68 164/11 1.5 30 40 BE stage 1 zone 3 Biweekly follow up Regressed
69 165/11 1.2 32 43 BE zone 3 mild
tortuosity
Biweekly follow up Regressed
70 162/11 1.2 32 37 BE stage 2 zone 3
6-12 o clock
position
Biweekly follow up Regressed
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140/10
1.8 28 39 RE stage 2 zone 3 ,
LE stage 1, zone 3
2-4 o clock
position
Biweekly follow up Regressed
72 159/11 1.2 29 35 RE zone 3 7-11 0
clock, stage 1,LE
zone 3, 1-5 o clock
stage 1
Biweekly follow up Regressed
73 169/11 1.5 32 35 RE zone 3 tortuos
vessels
Biweekly follow up Regressed
KEY:
RE         -         Right eye
LE           -       Left eye
BE          -        Both eye
ROP       -         Retinopathy of prematurity
ETROP   -        Early treatment of retinopathy of prematurity
ICROP    -        International classification of ROP
RD           -       Retinal detachment
